site_logo_drug_discovery.png

Genome-Wide CRISPR Screen - Drug Target Deconvolution

Scan the entire genome of your species of interest to determine where your drug molecules are targeting using our VERG platform

 

Ranomics' streamlined Genome-Wide CRISPR screen enables the characterization of thousands of gene knockouts to help you identify your drug's main targets, as well as potential off-target interactions.

 

Our analyses can be conducted in multiple cell lines to assess whether where your drug binds in tissue-specific or disease phenotype-specific cell lines.

Accelerate cell-based studies with Ranomics and identify high-quality drug targets faster.